煙霧病212例臨床分析
[Abstract]:Moyamoya disease, also known as the abnormal vessel network of the head of the brain, is one of the two-sided internal carotid artery (ICA) siphonage part and the anterior part of the brain, and the starting part of the central artery is very narrow or occluded, the base of the skull base is soft, A chronic cerebral vascular occlusive disease characterized by small blood vessel decompensation such as through-artery and the like. The clear cause of the smoke is not clear. The incidence, the type of the disease and the age of the disease are all the characteristics. Digital subtraction angiography (DSA) is a gold standard for diagnosis of this disease. Magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), computed tomography, CTA and the like have high sensitivity and specificity to the diagnosis of this disease. Appropriate internal surgical treatment is taken according to the disease characteristics of different patients. Methods: A retrospective study of 212 patients with smoke from January 2009 to December 2013 was carried out. A retrospective study of the clinical data related to it, including the time of admission, age, sex, ethnicity, type of onset, body, past medical history, family history, risk factors, laboratory and ultrasound imaging, treatment, and discharge The study data is analyzed using the SPSS17.0 statistical software, and the count data is verified by the Sup2. The p-value is 0.05 or 0.00 according to the case. 1. Results:1. According to the age division of the world health organization (WHO), 5.7% of the children, 35.4% of the youth, and 59 of the middle-aged and the elderly .0%. The number of middle-aged and old-aged patients is significantly higher than that of children and young people the number of patients. The number of patients with 45 to 60 years is more and more concentrated.2. 49.5% of the male patients,50 in the female .5%. The ratio of male to female is close to 1:1, and the overall sex ratio of the patient is not clear. Significant difference. Children's group, male 41.7%, female 58.3%; youth group, male 45.3%, female 54.7%; middle-aged and old-age group, male 52.8%, female 47 2%. There was no significant difference in the gender difference between the children's group, the young group and the middle-and-old-age group.3. The history of hypertension was 25.5%, the history of inoculation was 89.6%, the history of smoking was 35.8%, the history of drinking was 22.6%, and the history of smoking was 17. 9%. The history of hypertension, the history of vaccination, the history of smoking, and the history of drinking were the suspect risk factors of the disease.4. The group of children, 58.3% of the ischemic type, 41.7% of the blood group, 44.0% of the youth group, 44.0% of the ischemic type, 56.0% of the blood group, and 40 in the middle-aged and the elderly. .0%, blood type 60 .0%. According to the age group, there were no differences in the type of incidence among the three groups, and there was no difference in the type of the patients in the children's group, the young group and the middle-and-old-age group. There was no significant difference in the distribution of blood group among children, young people and middle-aged and old-aged and middle-aged and middle-aged and middle-aged and middle-aged patients. The CT combined with the CT and the CT combined with the transcranial Doppler (TCD) was 12.7%, the combination of the MRA and the MRA was 11.8% and the TCD combined with the neck-color 2. 8%. The above data shows that CT, CT, CTA, CT, TCD, MRA and MRA are combined with TCD. As a primary screening test, TCD and MRA have been applied to clinical screening.7. As a confirmed image, CTA2.8.3%, DSA40.6%, DSA and CTA14 It was found that CTA, DSA and DSA combined with CTA in the clinical application of CTA, DSA and DSA. The proportion of CTA in the diagnosis of smoke was significantly higher than that of other examinations (except for DSA).8. The patients with internal medicine were 84.4% and 15.6% of the patients with surgical treatment, and the patients were treated with internal medicine. The main.9, the medical treatment was relieved by 84.9%, with no relief of 15.1%; the surgical treatment was relieved by 87.9%, and the result was not relieved .1%. Total Response 85 .4%. The results of this study show that the surgical treatment is relieved The rate was high. There was no significant difference in the treatment of internal medicine and the effect of surgical treatment. There were 12 cases of children,7 cases of ischemic type, and hemorrhage. 5 cases of ischemic type,7 cases of ischemic internal medicine, All of them were relieved.3 cases were treated with blood group internal medicine,1 case was alleviated, 33.3% and 2 cases were not relieved, accounting for 66.7%, and the surgical treatment was 2 cases. The results showed that the treatment effect of the internal medicine of the children with ischemic type was remarkable, the surgical treatment effect of the children with blood group was remarkable.11,75 cases of the young patients,33 cases of the ischemic type, and the blood type 42 cases:32 cases of ischemic internal medicine and 1 case of surgical treatment In the treatment of 42 cases of blood group internal medicine,31 cases were relieved, 73.8% and 11 cases were not relieved, accounting for 26.2%, and the surgical treatment The results of this study indicated that the treatment effect of the internal medicine of the young ischemic type was significant, and there was a certain risk in the treatment of the patients with blood group. Of the 75 cases,41 cases were treated with ischemic internal medicine,37 cases were alleviated, 90.2% and 4 cases were not relieved, accounting for 9.8%, and the surgical treatment was 9 cases. The study indicated that the internal medicine and surgical treatment of the middle-and-old-aged and middle-aged and old-aged patients had significant effects. The results showed that 54 cases of blood group internal medicine were treated,44 cases were relieved, 81.5% and 10 cases were not relieved, accounting for 18.5%, the surgical treatment was 21 cases,17 cases were relieved, 81.0% and 4 cases were not relieved, accounting for 19%. In that middle-and-old-aged and old-age group, there was no difference in the effect of surgical treatment. The results showed that the internal medicine and surgical treatment of the middle-and-old-aged and old-aged patients had a certain risk.13. The indirect operation of the children and the indirect operation was directly combined with the indirect hand. 1 person. Young, direct + indirect. 1 person in the middle and old age:14 indirect operation,3 direct + indirect operation,7 aneurysm clipping + indirect operation, and aneurysm embolization/ clamp Closed 6 persons, indirect operation 45.4%, direct + indirect operation 15.2%, aneurysm clipping + indirect operation 21.2%, aneurysm embolization/ clipping 18 2%. The results of this study show that the indirect bridge operation and the combined operation are clinical. Conclusion:1. There is no significant difference in sex difference between 45 and 60 years. The history of hypertension, the history of inoculation, the history of smoking, and the history of alcohol consumption are the suspect risk factors of the smoke.3. There is no significant difference in the distribution of blood type and smoke in different ages. .4, CT, CT, CTA, CT, TCD, MRA and MRA combined with TCD. As a primary screening test, TCD and MRA were used in clinical screening. The treatment of medical treatment and surgical treatment is poor. There is no significant difference in medical treatment and surgical treatment. Significant remission rates. Indirect bridging and joint procedures can be applied to all ages
【學(xué)位授予單位】:吉林大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類號(hào)】:R743.3
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 晁迎九,凌鋒,張鵬,焦力群;神經(jīng)影像學(xué)評(píng)價(jià)顱內(nèi)外血管搭橋術(shù)的療效[J];安徽衛(wèi)生職業(yè)技術(shù)學(xué)院學(xué)報(bào);2005年01期
2 李建軍;那世杰;楊詠波;黃玉杰;王斌;;動(dòng)脈內(nèi)接觸性溶栓治療58例急性缺血性腦卒中[J];安徽醫(yī)學(xué);2010年05期
3 ~F立功;;微創(chuàng)顱內(nèi)血腫清除術(shù)治療高血壓腦出血的臨床分析[J];安徽醫(yī)學(xué);2011年05期
4 吳啟東,李曉廣,祁剛;高血壓殼核出血6例治療體會(huì)[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2003年05期
5 高宏斌;王武斌;湯加才;朱國(guó)慶;劉銘;;終池置管持續(xù)引流治療腦外傷術(shù)后腦脊液漏伴顱內(nèi)感染[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2008年03期
6 王秋生;;高血壓腦出血外科治療進(jìn)展[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2008年04期
7 魯虎臣;趙旭東;周怡婷;史繼新;;尼莫地平在防治蛛網(wǎng)膜下腔出血后腦血管痙攣的Meta分析[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2010年11期
8 曹永勝;程宏偉;馮春國(guó);;尼莫地平治療外傷性蛛網(wǎng)膜下腔出血后腦血管痙攣的療效觀察[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2011年11期
9 孟慶海,李國(guó)彬;顱內(nèi)動(dòng)脈瘤手術(shù)與介入治療效果比較[J];青島大學(xué)醫(yī)學(xué)院學(xué)報(bào);2003年01期
10 尹連虎;呂新兵;呂建華;孫超;王長(zhǎng)江;王浩;王剛;張洪兵;田力學(xué);;自發(fā)性蛛網(wǎng)膜下腔出血造影檢查陰性的原因分析[J];北京醫(yī)學(xué);2007年09期
相關(guān)會(huì)議論文 前3條
1 張迎春;席剛明;李自然;何玉芳;;顱內(nèi)動(dòng)脈瘤鉑金微彈簧圈栓塞術(shù)護(hù)理[A];湖北省神經(jīng)科學(xué)學(xué)會(huì)學(xué)術(shù)年會(huì)論文匯編[C];2007年
2 李成義;林貴軍;劉宗明;;自發(fā)性蛛網(wǎng)膜下腔出血死亡相關(guān)危險(xiǎn)因素分析[A];第二十三屆航天醫(yī)學(xué)年會(huì)暨第六屆航天護(hù)理年會(huì)論文匯編[C];2007年
3 劉曉東;;CT導(dǎo)引簡(jiǎn)易定位置管引流術(shù)治療高齡高血壓腦出血[A];增強(qiáng)自主創(chuàng)新能力 促進(jìn)吉林經(jīng)濟(jì)發(fā)展——啟明杯·吉林省第四屆科學(xué)技術(shù)學(xué)術(shù)年會(huì)論文集(下冊(cè))[C];2006年
相關(guān)博士學(xué)位論文 前10條
1 段傳志;腦動(dòng)脈瘤、動(dòng)靜脈畸形血管內(nèi)栓塞治療研究[D];中國(guó)人民解放軍第一軍醫(yī)大學(xué);2002年
2 黃慶;顱內(nèi)常見動(dòng)脈瘤的血液動(dòng)力學(xué)研究及動(dòng)脈瘤微彈簧栓塞預(yù)測(cè)程序的研制[D];中國(guó)人民解放軍第一軍醫(yī)大學(xué);2003年
3 劉力強(qiáng);PKC抑制劑對(duì)蛛網(wǎng)膜下腔出血性腦血管痙攣的防治作用及分子機(jī)制的實(shí)驗(yàn)研究[D];河北醫(yī)科大學(xué);2003年
4 郭元星;創(chuàng)傷性頸動(dòng)脈海綿竇瘺血管內(nèi)介入治療臨床應(yīng)用研究[D];第一軍醫(yī)大學(xué);2004年
5 王世波;大鼠蛛網(wǎng)膜下腔出血后腦微循環(huán)改變及星形膠質(zhì)細(xì)胞參與腦微循環(huán)調(diào)節(jié)的實(shí)驗(yàn)研究[D];中國(guó)人民解放軍軍醫(yī)進(jìn)修學(xué)院;2005年
6 蘇萬東;前循環(huán)動(dòng)脈瘤夾閉術(shù)后影響療效的多因素分析[D];山東大學(xué);2004年
7 郭付有;VSMC凋亡及其調(diào)控在腦動(dòng)脈瘤形成和破裂中的意義[D];四川大學(xué);2005年
8 李德生;腦血管內(nèi)皮細(xì)胞凋亡在大鼠蛛網(wǎng)膜下腔出血后血管痙攣中的作用及機(jī)制探討[D];中國(guó)人民解放軍軍醫(yī)進(jìn)修學(xué)院;2006年
9 趙叢海;Willis環(huán)前部動(dòng)脈瘤相關(guān)顯微解剖學(xué)研究及顯微手術(shù)技術(shù)的臨床應(yīng)用和治療結(jié)果分析[D];吉林大學(xué);2006年
10 陳光忠;腦動(dòng)靜脈畸形血管形態(tài)構(gòu)筑及相關(guān)生物學(xué)研究[D];第一軍醫(yī)大學(xué);2006年
相關(guān)碩士學(xué)位論文 前10條
1 梁曉;rhG-CSF經(jīng)鼻靶向中樞給藥對(duì)SAH后繼發(fā)性腦缺血損傷的保護(hù)作用[D];泰山醫(yī)學(xué)院;2010年
2 賈磊;基底節(jié)區(qū)高血壓腦出血的手術(shù)治療臨床分析[D];山東大學(xué);2010年
3 高巍;多層螺旋CTA對(duì)顱內(nèi)前交通動(dòng)脈瘤的應(yīng)用研究[D];吉林大學(xué);2011年
4 池國(guó)男;腦動(dòng)靜脈畸形的顯微外科手術(shù)治療(附109例病例資料)[D];吉林大學(xué);2011年
5 鄧志鋒;水凝膠彈簧圈聯(lián)合鉑金彈簧圈治療腦動(dòng)脈瘤的臨床研究[D];暨南大學(xué);2011年
6 凌芳;郴州地區(qū)高血壓腦出血的臨床特點(diǎn)分析[D];南華大學(xué);2011年
7 高連升;10例煙霧病的臨床特點(diǎn)及影像學(xué)分析[D];浙江大學(xué);2011年
8 向毅;影響前循環(huán)動(dòng)脈瘤手術(shù)預(yù)后的部分相關(guān)因素分析[D];天津醫(yī)科大學(xué);2011年
9 趙林;微創(chuàng)手術(shù)配合早期針灸治療高血壓腦出血臨床療效研究[D];遼寧中醫(yī)藥大學(xué);2011年
10 許英男;丹參酮ⅡA對(duì)蛛網(wǎng)膜下腔出血病人血漿鈣離子和內(nèi)皮素的影響[D];遼寧中醫(yī)藥大學(xué);2011年
本文編號(hào):2480203
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2480203.html